Biofrontera(CH:B8F)
CH:B8F
Biofrontera financials statements
Biofrontera (B8F) Income Statement
0 Followers
Biofrontera Income Statement
Last quarter (Q4 2023), Biofrontera's total revenue was €7.45M, an increase of 28.47% from the same quarter last year. In Q4, Biofrontera's net income was €5.92M. See Biofrontera’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| € 13.19M | € 12.18M | € 32.25M | € 25.74M | € 28.79M | |
| € 10.91M | € 10.12M | € 25.37M | € 20.98M | € 24.87M | |
| € 11.93M | € 11.70M | € 20.59M | € 19.39M | € 60.21M | |
| Depreciation and Amortization | € 648.00K | € 839.00K | € 791.00K | € 746.00K | € 3.29M |
| € -560.00K | € -301.00K | € 5.57M | € 2.34M | € -12.59M | |
| € -1.02M | € -1.59M | € 4.78M | € 1.59M | € -35.34M | |
| € -197.00K | € 436.00K | € -6.91M | € -44.80M | € 71.02M | |
| € -1.22M | € -1.15M | € -2.13M | € -43.21M | € 35.68M | |
| € -3.96M | € -4.35M | € -369.00K | € -44.17M | € 37.75M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.65 | € -0.72 | € -0.01 | € -0.77 | € 0.66 |
| Diluted EPS | € -0.65 | € -0.72 | € -0.01 | € -0.77 | € 0.65 |
| Weighted Average Shares Outstanding | 6.08M | 6.08M | 63.81M | 57.47M | 57.90M |
| Weighted Average Shares Outstanding (Diluted) | 6.08M | 6.08M | 63.81M | 57.47M | 59.29M |
Currency in EUR
